366 related articles for article (PubMed ID: 33030555)
1. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
[TBL] [Abstract][Full Text] [Related]
2. Oral β-lactams vs fluoroquinolones and trimethoprim/sulfamethoxazole for step-down therapy for Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae bacteremia.
McAlister MJ; Rose DT; Hudson FP; Padilla-Tolentino E; Jaso TC
Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S33-S41. PubMed ID: 35868628
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.
Wright SW; Wrenn KD; Haynes ML
J Gen Intern Med; 1999 Oct; 14(10):606-9. PubMed ID: 10571705
[TBL] [Abstract][Full Text] [Related]
4. Use of Fluoroquinolones or Sulfamethoxazole-Trimethoprim Compared to Β-Lactams for Oral Step-Down Therapy in Hospitalized Patients With Uncomplicated Enterobacterales Bacteremia.
Mack T; Hiles JJ; Wrin J; Desai A
Ann Pharmacother; 2023 Mar; 57(3):251-258. PubMed ID: 35758168
[TBL] [Abstract][Full Text] [Related]
5. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
Saad S; Mina N; Lee C; Afra K
BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial agents for treating uncomplicated urinary tract infection in women.
Zalmanovici Trestioreanu A; Green H; Paul M; Yaphe J; Leibovici L
Cochrane Database Syst Rev; 2010 Oct; (10):CD007182. PubMed ID: 20927755
[TBL] [Abstract][Full Text] [Related]
7. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
Junco SJ; Bowman MC; Turner RB
Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection.
Geyer AC; VanLangen KM; Jameson AP; Dumkow LE
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e148. PubMed ID: 37771747
[TBL] [Abstract][Full Text] [Related]
11. Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women.
Malik RD; Wu YR; Christie AL; Alhalabi F; Zimmern PE
Urology; 2018 Mar; 113():26-33. PubMed ID: 29196069
[TBL] [Abstract][Full Text] [Related]
12. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
Guibert J; Capron MH
J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Raz-Pasteur A; Liron Y; Amir-Ronen R; Abdelgani S; Ohanyan A; Geffen Y; Paul M
J Glob Antimicrob Resist; 2019 Jun; 17():168-172. PubMed ID: 30557685
[TBL] [Abstract][Full Text] [Related]
14. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V
BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
[TBL] [Abstract][Full Text] [Related]
16. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa.
Cotton MF; Wasserman E; Smit J; Whitelaw A; Zar HJ
BMC Infect Dis; 2008 Apr; 8():40. PubMed ID: 18380900
[TBL] [Abstract][Full Text] [Related]
17. Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated
Alzaidi S; Veillette JJ; May SS; Olson J; Jackson K; Waters CD; Butler AM; Hutton MA; Buckel WR; Webb BJ
Open Forum Infect Dis; 2024 Feb; 11(2):ofad657. PubMed ID: 38370295
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
Stein GE; Gurwith D; Gurwith M
Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
[TBL] [Abstract][Full Text] [Related]
19. Oral Fluoroquinolone or Trimethoprim-sulfamethoxazole vs. ß-lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis.
Punjabi C; Tien V; Meng L; Deresinski S; Holubar M
Open Forum Infect Dis; 2019 Aug; 6(10):. PubMed ID: 31412127
[TBL] [Abstract][Full Text] [Related]
20. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
